1. Academic Validation
  2. Trivalent Gd-DOTA reagents for modification of proteins

Trivalent Gd-DOTA reagents for modification of proteins

  • RSC Adv. 2015 Dec 9;5(116):96194-96200. doi: 10.1039/c5ra20359g.
Martin J Fisher 1 Daniel J Williamson 1 George M Burslem 1 Jeffrey P Plante 1 Iain W Manfield 2 Christian Tiede 2 James R Ault 2 Peter G Stockley 2 Sven Plein 3 Azhar Maqbool 3 Darren C Tomlinson 2 Richard Foster 4 Stuart L Warriner 1 Robin S Bon 5
Affiliations

Affiliations

  • 1 School of Chemistry , University of Leeds , LS2 9JT , UK . Email: r.bon@leeds.ac.uk; Astbury Centre for Structural Molecular Biology , University of Leeds , UK.
  • 2 Astbury Centre for Structural Molecular Biology , University of Leeds , UK ; School of Molecular and Cellular Biology , University of Leeds , UK.
  • 3 Leeds Institute of Cardiovascular and Metabolic Medicine , University of Leeds , UK ; Multidisciplinary Cardiovascular Research Centre , University of Leeds , UK.
  • 4 School of Chemistry , University of Leeds , LS2 9JT , UK . Email: r.bon@leeds.ac.uk; Astbury Centre for Structural Molecular Biology , University of Leeds , UK ; Multidisciplinary Cardiovascular Research Centre , University of Leeds , UK.
  • 5 School of Chemistry , University of Leeds , LS2 9JT , UK . Email: r.bon@leeds.ac.uk; Astbury Centre for Structural Molecular Biology , University of Leeds , UK ; Leeds Institute of Cardiovascular and Metabolic Medicine , University of Leeds , UK ; Multidisciplinary Cardiovascular Research Centre , University of Leeds , UK.
Abstract

The development of novel protein-targeted MRI contrast agents crucially depends on the ability to derivatise suitable targeting moieties with a high payload of relaxation enhancer (e.g., gadolinium(iii) complexes such as Gd-DOTA), without losing affinity for the target proteins. Here, we report robust synthetic procedures for the preparation of trivalent Gd-DOTA reagents with various chemical handles for site-specific modification of biomolecules. The reagents were shown to successfully label proteins through isothiocyanate ligation or through site-specific thiol-maleimide ligation and strain-promoted azide-alkyne cycloaddition.

Figures
Products